Weight Loss Management

With Compounded Samaglutide and Tirzepatide

Achieve lasting results with our compounded GLP-1 program. Clinical studies show patients experience an average weight loss of 15–20% over a 68-week period, with some losing up to 20% of their body weight.

Book A Consultation

See Real Results

At Emmanuel Clinics, our weight loss program is tailored to help you reach and maintain a healthy weight through safe, effective medical treatment. We specialize in the use of GLP-1 medications, which are FDA-approved and clinically proven to support long-term weight management by reducing appetite, improving insulin function, and promoting a feeling of fullness.

How It Works

Our team will evaluate your medical history, lifestyle, and weight goals to determine if you're a candidate for GLP-1 injections (such as Semaglutide or Tirzepatide). This program includes:

  • A personalized treatment plan

  • Ongoing provider supervision and progress monitoring

  • Nutritional and lifestyle guidance to support your journey

Start Your Journey

Book a consultation to see what weight-loss program is right for you!

Book Now

Frequently Asked Questions

  • Both medications are part of the GLP-1 family, but they work slightly differently. Semaglutide targets the GLP-1 receptor to reduce appetite and slow digestion, helping you feel full longer. Tirzepatide targets both the GLP-1 and GIP receptors, which may enhance blood sugar control and lead to greater average weight loss in some studies. Our providers will help you decide which option best fits your health goals.

  • Our compounded GLP-1 program uses medications that mimic natural hormones to regulate appetite, slow digestion, and support long-term weight loss.

  • Clinical studies show an average weight loss of 15–20% over a 68-week period. Individual results may vary based on your health, lifestyle, and commitment to the program.

  • Many patients notice changes in appetite and energy within the first few weeks, with steady weight loss typically beginning after the first month.

  • Yes. When prescribed and monitored by our medical team, GLP-1 medications are safe and effective. We closely monitor progress and adjust treatment as needed.

  • Some patients may experience mild nausea, bloating, or digestive discomfort at the start. These effects usually lessen over time as the body adjusts.

  • GLP-1 medications are typically administered as a small weekly injection. Our team will teach you how to self-administer safely and comfortably.

  • Coverage varies by plan. We can discuss options with you and provide affordable compounded alternatives when insurance does not apply.